Log in

NASDAQ:CDLXCardlytics Stock Price, Forecast & News

$29.72
-0.91 (-2.97 %)
(As of 04/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$28.57
Now: $29.72
$31.30
50-Day Range
$29.49
MA: $62.11
$102.99
52-Week Range
$14.14
Now: $29.72
$107.50
Volume912,366 shs
Average Volume1.25 million shs
Market Capitalization$678.51 million
P/E RatioN/A
Dividend YieldN/A
Beta2.53
Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.
Read More
Cardlytics logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.2Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.68 out of 5 stars


Industry, Sector and Symbol

Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorBusiness Services
Current SymbolNASDAQ:CDLX
CUSIPN/A
Phone888-798-5802

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$210.43 million
Book Value$6.28 per share

Profitability

Net Income$-17,140,000.00

Miscellaneous

EmployeesN/A
Market Cap$678.51 million
Next Earnings Date5/14/2020 (Estimated)
OptionableNot Optionable

Receive CDLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.


Cardlytics (NASDAQ:CDLX) Frequently Asked Questions

How has Cardlytics' stock been impacted by COVID-19 (Coronavirus)?

Cardlytics' stock was trading at $45.83 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CDLX stock has decreased by 35.2% and is now trading at $29.72. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cardlytics?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cardlytics.

When is Cardlytics' next earnings date?

Cardlytics is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Cardlytics.

How were Cardlytics' earnings last quarter?

Cardlytics Inc (NASDAQ:CDLX) announced its quarterly earnings data on Tuesday, March, 3rd. The company reported $0.18 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.04 by $0.14. The business earned $69.29 million during the quarter, compared to the consensus estimate of $69.19 million. Cardlytics had a negative return on equity of 19.49% and a negative net margin of 8.15%. The firm's revenue was up 44.9% on a year-over-year basis. During the same period last year, the firm earned ($0.06) EPS. View Cardlytics' earnings history.

What guidance has Cardlytics issued on next quarter's earnings?

Cardlytics updated its first quarter 2020 After-Hours earnings guidance on Tuesday, March, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $43.5-46.5 million, compared to the consensus revenue estimate of $52.77 million.

What price target have analysts set for CDLX?

7 brokerages have issued 1 year price targets for Cardlytics' shares. Their forecasts range from $26.00 to $100.00. On average, they expect Cardlytics' stock price to reach $62.17 in the next year. This suggests a possible upside of 109.2% from the stock's current price. View analysts' price targets for Cardlytics.

Has Cardlytics been receiving favorable news coverage?

Media headlines about CDLX stock have been trending very negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Cardlytics earned a news impact score of -3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutCardlytics.

Who are some of Cardlytics' key competitors?

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include Trade Desk (TTD), Alibaba Group (BABA), Caterpillar (CAT), Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Square (SQ), Crispr Therapeutics (CRSP), Roku (ROKU) and Netflix (NFLX).

Who are Cardlytics' key executives?

Cardlytics' management team includes the following people:
  • Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 56)
  • Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 49)
  • Mr. David Evans, CFO & Head of Corp. Devel.
  • Mr. Sathish Gaddipati, Chief Technology Officer (Age 52)
  • Mr. Kirk L. Somers, Chief Legal & People Officer (Age 54)

When did Cardlytics IPO?

(CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

What is Cardlytics' stock symbol?

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

How do I buy shares of Cardlytics?

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cardlytics' stock price today?

One share of CDLX stock can currently be purchased for approximately $29.72.

How big of a company is Cardlytics?

Cardlytics has a market capitalization of $678.51 million and generates $210.43 million in revenue each year. The company earns $-17,140,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis.  View additional information about Cardlytics.

What is Cardlytics' official website?

The official website for Cardlytics is http://www.cardlytics.com/.

How can I contact Cardlytics?

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]

This page was last updated on 4/4/2020 by MarketBeat.com Staff

Featured Article: Elliott Wave Theory

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel